This bill matters because it represents a shift in the balance between patient privacy and public safety in the context of the opioid crisis and broader substance use challenges. If it becomes law, it could help reduce drug-related harm by allowing healthcare providers to have a more complete understanding of all medications a patient is receiving, including those for addiction treatment. This fuller picture could help prevent dangerous drug interactions, duplicate prescriptions, and doctor shopping.

However, it also means that highly sensitive medical information about substance use disorder treatment, which has traditionally been afforded extra protections, could become part of state prescription databases. Voters should care about whether the potential benefits of improved prescribing safety outweigh the concerns about increased disclosure of private health information, and how this might impact individuals seeking help for addiction.